Home > Research Areas > Neurological Disease
Cat. No. Product name CAS No.
DC11019 ASP3662

ASP3662 is a potent, selective, CNS-penetrable and orally active inhibitor of 11β-HSD1 with Ki of 5.3, 2.6 and 23 nM for human, mouse and rat 11β-HSD1, does not inhibit human 11β-HSD2 at 30 uM.

1204178-50-6
DCS-019 (-)-Huperzine A

>98%,Standard References

102518-79-6
DCJ-030 Galanthamine

>98%,Standard References

357-70-0
DCL-027 Lipoic acid

>98%,Standard References

62-46-4
DCH-043 Tetrodotoxin

>98%,Standard References

4368-28-9
DCL-011 Capsaicin

>98%,Standard References

2444-46-4
DC11936 TAK-915

A highly potent, selective, brain-penetrating and orally active phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 0.61 nM.

1476727-50-0
DC11523 Landipirdine

A novel 5-HT receptor antagonist for the treatment of Parkinson's disease..

1000308-25-7
DC11674 PF-DcpSi

A potent inhibitor of the mRNA decapping scavenger enzyme (DcpS) with IC50 of 0.11 nM.

2092917-19-4
DC11514 Atogepant

A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine. Migraine.

1374248-81-3
DC11838 Org 25935

A potent, selective glycine transporter 1 (GlyT1) inhibitor with IC50 of 100 nM.

949588-40-3
DC11895 Foliglurax hydrochloride

A potent, selective, brain-penetrant and orally bioavailable mGluR4 positive allosteric modulator with EC50 of 79 nM.

2133294-96-7
DC11894 Foliglurax

A potent, selective, brain-penetrant and orally bioavailable mGluR4 positive allosteric modulator with EC50 of 79 nM.

1883329-51-8
DC11491 A-1048400

A-1048400(A 1048400) is a novel potent, selective, orally active N-type and T-type calcium channel blocker with IC50 of 1.4 and 1.2 uM, respectively.

1219624-62-0
DC11490 A-317567

A-317567 (A317567) is a novel potent acid sensing ion channel (ASIC) blocker with IC50 of 2-30 uM.

371217-32-2
DC7351 A-740003

A-740003 is potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively).

861393-28-4
DC9706 ABT-639 Featured

ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker. ABT-639 blocks recombinant human T-type (Cav3.2) Ca2+ channels in a voltage-dependent fashion (IC50 = 2 μM) and attenuates LVA currents in rat DRG neurons (IC50 = 8 μM).

1235560-28-7
DC11155 ABX-1431 Featured

ABX-1431 (ABX1431) is a highly potent, selective, orally available, CNS-penetrant monoacylglycerol lipase (MGLL) with IC50 of 14 nM (hMGLL).

1446817-84-0
DC11183 ABX-1431 hydrochloride Featured

ABX-1431 (ABX1431) is a highly potent, selective, orally available, CNS-penetrant monoacylglycerol lipase (MGLL) with IC50 of 14 nM (hMGLL).

2043074-64-0
DC9900 Acetaminophen

Acetaminophen is a COX inhibitor for COX-1 and COX-2 with IC50 of 113.7 μM and 25.8 μM, respectively.

103-90-2
DC11439 Nemorexant

ACT-541468 is a dual orexin receptor antagonist.

1505484-82-1
DC8476 ACY-738 Featured

ACY-738 demonstrates inhibitory activity against recombinant HDAC6 with IC50 values of 1.7 nM, with respective average selectivity over class I HDACs being 100-fold.

1375465-91-0
Page 1 / Total 8 FirstPrevNextLastGoto